Abstract

Genomics has the potential to revolutionize medical approaches to disease prevention, diagnosis, and treatment, but it does not come without challenges. The success of a national population-based genome program, like the Qatar Genome Program (QGP), depends on the willingness of citizens to donate samples and take up genomic testing services. This study explores public attitudes of the Qatari population toward genetic testing and toward participating in the QGP. A representative sample of 837 adult Qataris was surveyed in May 2016. Approximately 71% of respondents surveyed reported that they were willing to participate in the activities of the QGP. Willingness to participate was significantly associated with basic literacy in genetics, a family history of genetic diseases, and previous experience with genetic testing through premarital screening. Respondents cited the desire to know more about their health status as the principle motivation for participating, while lack of time and information were reported as the most important barriers. With QGP plans to ramp up the scale of its national operation toward more integration into clinical care settings, it is critical to understand public attitudes and their determinants. The results demonstrate public support but also identify the need for more education and individual counseling that not only provide information on the process, challenges, and benefits of genomic testing, but that also address concerns about information security.

Highlights

  • Precision health is a new paradigm that is increasing the use of genomic technologies for the assessment of susceptibility to major diseases as well as individual responses to therapeutic regimes [1, 2], increasing the effectiveness of medical intervention

  • Almost one-half of respondents (51.2%) had heard of genetic testing, while only 27.8% reported having heard of genomic tests

  • Respondents were asked about their awareness of genetic testing, and we observed that slightly more than half of the respondents had previously heard about genetic tests

Read more

Summary

Introduction

Precision health is a new paradigm that is increasing the use of genomic technologies for the assessment of susceptibility to major diseases as well as individual responses to therapeutic regimes [1, 2], increasing the effectiveness of medical intervention. Evidence is pointing to the influence of precision health on improved treatment and health outcomes for patients with breast [3], lung [4], and colorectal [5] cancers. Realizing this potential, and aided by the rapid evolution of sequencing technology, several countries have embarked on national projects to characterize the genomes of their own populations in preparation for large-scale implementation in clinical settings [1]. With a native population of around 300,000 citizens, state of the art genomic infrastructure, and a centralized and dynamic health care system, Qatar has all the essential ingredients for becoming a global model in implementing precision medicine

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call